Introduction
Pigs are raised throughout the world as a meat production animal. Selection for high growth rate and lean meat deposition has resulted in the decline of pork quality. In recent years, consumers pay particular attention to pork quality. Therefore, it is necessary to identify candidate genes that might contribute to pork quality.
Sine oculis homeobox 1 (Six1), a member of the Six family of homeodomain transcription factors, plays an indispensable role in skeletal myogenesis and specification of myofiber diversity Grifone et al., 2004; Bessarab et al., 2008) . Six1 is highly expressed in fast-twitch muscles and is related to the formation of fast-type muscle fibers (Xu et al., 2003; Niro et al., 2010) . Knockdown of Six1 caused a fastto-slow shift in myosin heavy chain isoforms, which is the most appropriate marker for fiber type delineation (Hetzler et al., 2014) . It is well known that the skeletal muscle fiber is closely related to meat quality (Henckel et al, 1997; Maltin et al., 1997) . Thus, Six1 as a candidate gene that may play a potential role in porcine skeletal muscle development and pork quality traits still needs to be studied further.
There are some reports in the literature concerning the porcine Six1 (pSix1). Wu et al. (2011) cloned the pSix1 gene full-length cDNA, genomic DNA, and proximal promoter sequence and examined the expression of pSix1 mRNA in various tissues. Subsequently, they evaluated the role of distinct domains of pSix1 in subcellular localization (Wu et al., 2012) . More recently, Wu et al. (2013) determined the core promoter region of the pSix1 gene, analyzed the effects of DNA methylation on its promoter activities in vitro, and detected the methylation levels of its core region in different tissues or different muscles.
In the present study, the pSix1 gene was cloned into prokaryotic expression vector pET30a(+) and successfully expressed in Escherichia coli. The recombinant pSix1 was purified by affinity column and used for polyclonal antibody preparation by immunizing Sprague Dawley rats. The antibody titer and specificity were determined by ELISA and western blot analysis. The tissue distribution of pSix1 was assessed by western blot using the prepared polyclonal antibody.
as the protein expression host. The pET-30a(+) vector (Novagen, USA) was used to construct the expression plasmid. A UNIQ-10 Spin Column DNA Gel Extraction Kit, kanamycin sulfate, and Ni-IDA purification system were obtained from Sangon Corporation (China). The restriction enzymes NdeI and XhoI and a DNA ligation kit were purchased from TaKaRa (China). The 2X Taq PCR master mix, DNA marker, and protein molecular weight marker (low) were obtained from TIANGEN Biotech. The prestained protein molecular weight marker was purchased from Beyotime Company (China). The monoclonal anti-His (C-term) antibody was purchased from Invitrogen (USA). The ο-phenylenediamine (OPD) was purchased from Shanghai Chemicals (China). The horseradish peroxidase (HRP)-conjugated goat antirat IgG was purchased from Santa Cruz Biotechnology, Inc. (USA).
Plasmid construction for E. coli expression
Total RNA was extracted from the longissimus lumborum (LL) muscle of a 10-week-old female Duroc × Landrace × Yorkshire (DLY) pig using RNAiso Plus reagent (TaKaRa) according to the manufacturer's instructions. The concentration of total RNA was determined using a Beckman DU-800 spectrophotometer (Beckman Coulter, USA) and 1 µg of total RNA was reverse transcribed using a PrimeScript RT reagent Kit with the gDNA Eraser (TaKaRa) according to the manufacturer's protocols.
The pSix1 gene (GenBank accession no. NM_001199718) was amplified by PCR with the specific primers pET-30a(+)-pSix1CDS-F (5'-CCCAATTCCATATGTCGATGCTGCC ATCGTTCGGCTTC-3') and pET-30a(+)-pSix1CDS-R (5'-AAACTCGAGGGACCCTAAGTCCACCAGACTG GAG-3') (the restriction enzyme sites NdeI and XhoI are underlined). The amplified PCR products were doubledigested with NdeI and XhoI, gel-purified, and ligated into the pET-30a(+) expression vector doubly digested with the same restriction enzymes. The ligation product was transformed into E. coli DH5α. The positive clone was confirmed by colony PCR and DNA sequencing analysis. Theoretically, the resulting recombinant plasmid, defined as pET-30a(+)-pSix1, can express a fusion protein corresponding to pSix1 carrying the extra C-terminal sequence 6-His tag, which is beneficial for the fusion protein purification by Ni 2+ -chelating affinity.
Expression of the recombinant protein
The recombinant plasmid pET-30a(+)-pSix1 was transformed into E. coli BL21 (DE3). The empty plasmid pET-30a(+) was used as a control. The transformants were inoculated into 5 mL of Luria-Bertani (LB) liquid medium containing 50 µg/mL of kanamycin and allowed to grow overnight at 37 °C in a shaker at 250 rpm. The resulting seed culture was then transferred into 15 mL of fresh LB medium with 50 µg/mL of kanamycin in a 100-mL flask. When the strains reached logarithmic phase (OD 600 = 0.4-0.6), protein expression was induced by the addition of isopropyl-β-D-thiogalactopyranoside (IPTG; 2 mM) and the culture temperature was reduced to 30 °C. After induction of 0, 1, 2, 3, 4, 5, 6, 7, and 8 h, 1 mL of the bacterial culture was harvested and centrifuged at 6000 rpm for 10 min at 4 °C. The bacterial pellets were lysed in 5X sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer (0.313 M Tris-HCl, pH 6.8, 50% glycerol, 10% SDS, 0.05% bromophenol blue, and 100 mM DTT) and then analyzed by 12% SDS-PAGE.
To optimize IPTG concentration, recombinant fusion protein expression was induced with different concentrations of IPTG (0, 0.5, 0.75, 1, 2, and 3 mM) for 2 h. The recombinant fusion protein was harvested as described above and assessed by 12% SDS-PAGE. The gel was then assessed according to Image Lab software (Version 4.1, Bio-Rad, USA).
Solubility testing
To determine the solubility or insolubility of the recombinant protein, for the initial experiment, log phase cultures were induced with 2 mM IPTG for 2 h at 30 °C, and 50 mL of the induced cells were harvested according to the above method. The bacterial pellets were resuspended in 5 mL of broken lysis buffer (50 mM Tris-HCl, pH 8.0, 0.1% Triton X-100, 5 mM EDTA, 1 mM phenylmethanesulfonyl fluoride). The suspension was sonicated on ice (2 s working and 5 s resting, 260 W) until the sample was clear. The resulting cell lysates were fractionated by centrifugation at 12,000 rpm for 30 min at 4 °C. The clear supernatants (soluble fraction) and remaining pellets (insoluble fraction) were analyzed in parallel using 12% SDS-PAGE.
Purification of the recombinant protein
After induction, the cultured cells from trial 50-mL cultures were harvested by centrifugation at 6000 rpm for 10 min at 4 °C. The supernatant fractions were removed and the pellet fractions were resuspended and dissolved in 3 mL of Ni-Denature-GuHCl buffer (100 mM NaH 2 PO 4 , 300 mM NaCl, 6 M GuHCl, pH 8.0) followed by centrifugation at 12,000 rpm for 20 min at 4 °C. The clear supernatants were then filtrated with a 0.45-µm filter and loaded onto a 1-mL prepacked Ni-IDA column equilibrated by 10 column volumes of Ni-Denature-urea buffer (100 mM NaH 2 PO 4 , 300 mM NaCl, 8 M urea, pH 8.0). The bound His-tagged fusion protein was eluted with 5 column volumes of NiNative-250 buffer (100 mM NaH 2 PO 4 , 300 mM NaCl, 250 mM imidazole, 8 M urea, pH 8.0). The concentration of the collected sample was assessed using the BCA protein assay kit (Pierce, USA). The purified protein was then verified by 12% SDS-PAGE followed by staining with Coomassie Brilliant Blue R250.
Preparation of polyclonal antibody against pSix1
The purified recombinant pSix1 was used for producing antibodies in Sprague Dawley rats. Prior to immunization, 1 mL of blood was collected from each rat via nicks in the tail vein; blood stood for 1 h at 37 °C and 4 °C overnight and was then centrifuged at 5000 rpm for 20 min at 4 °C. The serum was gathered as a negative control. After that, Sprague Dawley rats were first immunized by multipoint subcutaneous injection on the back using a mixture of 300 µg of purified recombinant pSix1 with an equal volume of Freund's complete adjuvant. After 2 weeks, 3 booster injections were given with a mixture of 200 µg of purified recombinant pSix1 each in incomplete Freund's adjuvant at intervals of 10 days. Subsequently, the blood was obtained 1 week after the last injection. The antiserum was gathered according to the above method and then stored at -80 °C until further use.
Tissue sample collection and protein extraction
Three 10-week-old female DLY pigs with a body weight of 31 to 31.6 kg were slaughtered in a humane manner according to protocols approved by the Animal Care Advisory Committee of Sichuan Agricultural University. The extensor digitorum longus (EDL) muscle, soleus (SOL) muscle, psoas major (PM) muscle, LL muscle, abdominal fat, heart, liver, and kidney were removed and immediately snap-frozen in liquid nitrogen before being stored at -80 °C for protein extraction.
Protein extraction was performed according to an ordinary procedure (Zheng et al., 2014) . Briefly, after 100 µg of tissue sample was ground to powder in liquid nitrogen, 500 µL of RIPA buffer (25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) containing protease inhibitor cocktail (Sigma) was added. The tissue extracts were centrifuged at 14,000 × g for 20 min at 4 °C and the supernatant was frozen in aliquots at -80 °C. The protein concentration was determined with the BCA protein assay kit (Pierce). 2.8. Antibody titer determination by ELISA Indirect enzyme-linked immunosorbent assay (ELISA) was used to determinate the titer of antiserum. The purified recombinant pSix1 (antigen) diluted to 3 µg/mL in 50 mM carbonate salt buffer (pH 9.6) was coated on immunoplates at 100 µL per well and incubated for 1 h at 37 °C and 4 °C overnight. The coated wells were washed 3 times with phosphate-buffered saline (PBS)-Tween buffer (0.05% Tween-20 in 0.01 mol/L PBS) and then blocked with 150 µL of blocking buffer (1% gelatin in carbonate salt buffer) for 1 h at 37 °C. After washing 3 times with PBSTween buffer, the coated wells were incubated with 100 µL of polyclonal antibodies against pSix1 with different consecutive dilutions (from 1:1280 to 1:81,920) at 37 °C for 1 h. After incubation, the coated cells were washed 3 times with PBS-Tween buffer followed by incubation with 100 µL of HRP-conjugated goat antirat IgG diluted at 1:5000 at 37 °C for 1 h. After washing 3 times with PBS-Tween buffer, the coated wells were reacted with OPD and H 2 O 2 as the substrate of peroxidase. After 20 min, the reaction was stopped by 50 µL of 2 M H 2 SO 4 . The optical density of each well was then measured at 490 nm using a microplate reader (Bio-Rad).
Western blot analysis
Western blot analysis was performed as before . Briefly, after the proteins had been separated by 12% SDS-PAGE, the gel was immersed in the transfer buffer (25 mM Tris base, 192 mM glycine, and 20% methanol). The proteins were transferred to a nitrocellulose membrane equilibrated in transfer buffer using the SemiDry Trans-Blot System (Bio-Rad) at 20 V for 30 min. The membrane was incubated in a blocking buffer (3% BSA in 0.01 mol/L PBS) for 1 h at room temperature and then washed 3 times (10 min each) with PBS/T (0.01 mol/L PBS and 0.1% Tween-20). The membrane was incubated with the monoclonal anti-His (C-term) antibody (1:2000) or the prepared anti-pSix1 polyclonal antibody (1:2000) overnight at 4 °C. After 3 washes (10 min each) with PBS/T, the membrane was incubated with HRPconjugated secondary antibodies at a dilution of 1:5000 at 37 °C for 1 h. The membrane was then washed 3 times with PBS/T and 1 time with PBS. The signals were visualized with SuperSignal West Pico Chemiluminescent Substrate (Pierce) and a ChemiDoc XRS Imager System (Bio-Rad).
Results

Construction of the expression plasmid
A full-length 852-bp pSix1 gene fragment was amplified by RT-PCR from skeletal muscle of a DLY pig. The pSix1 gene was successfully inserted into expression vector pET30a(+) between the NdeI and XhoI restriction sites and the recombinant plasmid pET30a(+)-pSix1 was confirmed by colony PCR and DNA sequencing. No mutation was found in the nucleotide sequence of the inserted fragment after DNA sequencing (data not shown). The recombinant plasmid construction is illustrated in Figure 1 . The recombinant plasmid contains a sequence of the 6-His C-terminal tag, which is beneficial to purify the target protein.
Expression of the recombinant protein
To obtain recombinant pSix1, the confirmed pET-30a(+)-pSix1 plasmid was used to express the fusion protein in the expression host E. coli BL21 (DE3). Culture conditions, including optimal induction time and IPTG concentration, were varied. As shown in Figure 2 , an evident band of approximately 33 kDa, consistent with the predicted size of the pSix1 fusion protein (the addition of target protein, 32 kDa, and histidine marker, 1 kDa), was observed. The recombinant pSix1 was effectively expressed in the E. coli BL21 (DE3) when the culture was induced with 2.0 mM IPTG for 2 h at 30 °C (Figure 2 ).
Solubility testing
The solubility or insolubility of the recombinant protein was examined after sonication. As shown in Figure 3 , the recombinant pSix1 was mainly expressed as inclusion bodies in the insoluble fraction.
Purification of the recombinant protein and identification by Western blot
The His6-tagged recombinant protein was expressed as inclusion bodies, so the Ni-Denature-GuHCl buffer containing 6 M guanidine hydrochloride as a strong denaturant was used for purifying the insoluble fraction through Ni 2+ -affinity chromatography. After binding to the resin, the target protein was successfully eluted with 250 mM imidazole elution buffer. The collected sample was analyzed by SDS-PAGE, and a single homogeneous band of about 33 kDa was observed ( Figure 4A ). The resulting purified fusion protein was more than 90% and approximately 4.6 mg/L of pure recombinant pSix1 was obtained. The purified protein was further identified by western blot analysis using the monoclonal anti-His (C-term) antibody and a specific band of approximately 33 kDa was detected ( Figure 4B ).
Antiserum titer and specificity analysis by ELISA and western blot
After immunizing Sprague Dawley rats with the purified recombinant pSix1 according to standard protocols, the antiserum was collected. The polyclonal antibody titer was examined by ELISA and the antiserum with different dilutions from 1280 to 81,920 was used to react with the antigen. The antibody titer was defined as the highest dilution of serum at which the A490 of postimmunization serum/A490 of preimmunization serum was greater than 2.1 . As shown in Figure 5 , the antibody titer was approximately 1:40,960.
After determining the antiserum titer by ELISA, the activity and specificity of the polyclonal antibody raised against pSix1 was further determined by western blot. The result showed a single band in the correct position (Figure 6 ), indicating that the recombinant pSix1 could be recognized by the polyclonal antibody. The same sample was also incubated with the preimmunization serum but no reaction was observed (data not shown).
Tissue distribution of pSix1
Expression of pSix1 in various tissues was assessed by western blot using the prepared anti-pSix1 polyclonal antibody. As shown in Figure 7 , pSix1 protein was abundant in the EDL muscle and LL muscle; it could also be detected in the SOL muscle and PM muscle, but not in the abdominal fat, heart, liver, or kidney.
Discussion
In this study, we chose the T7-based pET expression system to produce the recombinant protein since the expression system has benefits like a fast growth rate, easy operation procedure, high yield of the target protein, and easy purification procedure. The pSix1 gene was amplified, cloned into the pET30a(+) vector, and successfully expressed in E. coli. The recombinant plasmid contains the target pSix1 gene with only a His6 tag fusion partner in the C-terminal to purify the recombinant protein specifically.
After optimization of the induction conditions with 2 mM IPTG for 2 h at 30 °C, the yield of the target fusion protein was significantly improved. We then found that the fusion protein was predominantly expressed as inclusion bodies, so the insoluble bodies were resolubilized by strong denaturants of 6 M guanidine hydrochloride and 8 M urea. Resolubility was purified by Ni-IDA affinity chromatography and identified by western blot analysis using the monoclonal anti-His (C-term) antibody. The result indicates that the purified recombinant protein was the target protein. The correctly folded active pSix1 protein could be obtained by step dilution method . The refolded purified recombinant pSix1 will be useful for further studies on its biological functions.
The Sprague Dawley rats were immunized with the purified recombinant protein and the polyclonal antibodies against pSix1 were raised. The antibody titer was determined by ELISA analysis and was found to have a high degree of detectable sensitivity, approximately 1:40,960. The specificity of polyclonal antibody was examined by western blot analysis and the result suggests that the polyclonal antibody can recognize recombinant pSix1 with high activity and specificity. Expression of pSix1 mRNA in various tissues has been previously determined by semiquantitative RT-PCR (Wu et al., 2011) . pSix1 mRNA is highly expressed in the skeletal muscle, testicle, and bone marrow, whereas the expression in other tissues is relatively low or absent (Wu et al., 2011) . Mammalian skeletal muscles are generally classified as fast and slow types based on the ratio of slow-and fast-type muscle fibers (Schiaffino and Reggiani, 2011) . EDL muscle and LL muscle are typical fast muscles, while SOL muscle and PM muscle are typical slow muscles (O'Connor et al., 2003; Wang et al., 2012; Liu et al., 2013) . Here we have shown that pSix1 protein was most abundant in the EDL muscle and LL muscle, followed by the SOL muscle and PM muscle, while it could not be detected in other tissues. Our data indicated that pSix1 protein expression was significantly higher in fast muscles than in slow muscles. Aside from the dominant 32-kDa band, there is a slight band above 32 kDa shown in Figure 7 , suggesting that the endogenous pSix1 protein is posttranslationally modified or processed. A similar result was also observed in human Six1 transfected MCF7 cells (Ford et al., 2000) . In summary, we first expressed the pSix1 gene in E. coli and obtained a high yield of target proteins. The recombinant pSix1 was purified by affinity column and identified by western blot. The protein size was consistent with the predicted molecular weight. The purified recombinant pSix1 was used for producing polyclonal antibodies and the antibody titer and specificity were determined by ELISA and western blot analysis, respectively. This study provides a simple and efficient method for yielding sufficient quantities of recombinant pSix1 and preparing polyclonal antibodies against pSix1, which would be useful for further study of the pSix1 protein. The pSix1 protein level was found to be more abundant in fast muscles than in slow muscles, which prompts us to examine whether pSix1 is involved in the porcine muscle fiber type formation and whether it has a close relationship with pork quality in future investigations. 
